Bruker launches new timsTOF-based MALDI PharmaPulse systemBy The Science Advisory Board staff writers
February 8, 2022
The new timsTOF MPP is the flagship of Bruker's MALDI PharmaPulse product family. The timsTOF MPP features the speed and robustness of MALDI, Bruker said. And, for the first time in HTS, the MPP takes advantage of Bruker's innovative tims technology. Tims enables rapid gas-phase separation of isobars, and even isomers, by exploiting the molecular collisional cross section. This, in combination with routine 50,000 mass resolution at full speed with quadropole time-of-flight mass spectrometry detection, enables revolutionary levels of assay specificity at HTS speed.
The timsTOF MPP features a dual MALDI/electrospray ionization ion source with a 10-kHz Smartbeam 3D laser to enable uHTS-compatible speed and throughput. The new MALDI PharmaPulse 2023 software supports a broad range of HTS applications for drug discovery, Bruker added.
Bruker's scientific instruments and analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.